Diseases & Disorders
(G300)
DX Registered
990 on File
BLOOD CANCER UNITED INC
Financial strength (30%)
70/100
Reliability (20%)
70/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$358.7M
Total Revenue
$398.1M
Total Expenses
$360.5M
Net Assets
1390
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
74.3%
Fundraising Efficiency
297.3%
Operating Reserve
10.87x
Liability-to-Asset
32.3%
Revenue Diversification
87.9%
Executive Compensation
$3.3M
Compared with Peers
FY 2025
Compared with 15 similar organizations
(United States, Diseases & Disorders, $100M and over in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
74.3% | 83.5% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
13.2% | 8.8% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
12.5% | 10.7% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
297.3% | 567.2% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
10.9 mo | 9.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
32.3% | 29.1% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
87.9% | 91.8% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-2.6% | 5.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
7.1% | 4.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-11.0% | 0.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $358.7M | $398.1M | $360.5M | 74.3% | 1390 |
| 2024 | $368.2M | $371.8M | $391.0M | 74.6% | 1228 |
| 2023 | $378.3M | $386.1M | $372.6M | 71.8% | 1181 |
| 2022 | $427.0M | $518.6M | $371.9M | 79.3% | 1177 |
| 2021 | $477.7M | $359.8M | N/A | — | 1300 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.